Inside BioStack's $9.5M Seed Round: Building a Global Clinical Data Layer
Dr. Dereck Mush, MD, MBA
BioStack
Healthcare data infrastructure connecting longitudinal clinical records for medical AI and biotechnology research.
What they do
BioStack connects notes, laboratory results, imaging, medications and treatment outcomes across healthcare systems, creating de-identified datasets for research and medical AI development. Its October 22, 2026 announcement reported $9.5 million in seed funding and a network spanning the United States, India, Brazil and Argentina. These are company-reported operational details.
The record
- Vertical
- Health Data Infrastructure
- Sub-segment
- Multimodal clinical data
- Product type
- Platform software
- Stage
- Seed
- Headquarters
- San Francisco, CA, USA
- Region
- North America
- Founded
- Not disclosed
- Total funding
- $9.5M raised
Notable investors: Peak XV Partners, Afore Capital, DCVC, Emerson Collective, SV Angel, Verdict Capital, Streamlined Ventures, Y Combinator.
Also in Health Data Infrastructure
Related on The Signal
Dr. Dereck Mush, MD, MBA
The EHR Dark Data Goldmine: Why Sentence-Level Provenance Is Pharma's New Real-World Evidence Moat
Dr. Dereck Mush, MD, MBA
Beyond PD-L1: How the I3LUNG Consortium Validated Multimodal AI in 2,365 Advanced Lung Cancer Patients
Dr. Dereck Mush, MD, MBA
Oracle and AstraZeneca: Bringing Clinical Trials Closer to Care
Dr. Dereck Mush, MD, MBA